Intercept Pharmaceuticals, Inc.

UBS Group AG

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/9/2023

Shares

2,999,188

Value ($000)

55,605

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/9/2023	55,605	0.0%	2,999,188	9/30/2023
2023 Q2	8/11/2023	15,036	0.0%	1,359,471	6/30/2023
2023 Q1	5/12/2023	1,654	0.0%	123,148	3/31/2023
2022 Q4	2/8/2023	2,552	0.0%	206,318	12/31/2022
2022 Q3	11/10/2022	809	0.0%	58,025	9/30/2022
2022 Q2	8/10/2022	1,289	0.0%	93,290	6/30/2022
2022 Q1	5/16/2022	2,904	0.0%	178,480	3/31/2022
2021 Q4	2/14/2022	2,312	0.0%	141,862	12/31/2021
2021 Q3	11/15/2021	3,878	0.0%	261,199	9/30/2021
2021 Q2	8/13/2021	2,406	0.0%	120,452	6/30/2021
2021 Q1	5/12/2021	3,162	0.0%	137,000	3/31/2021
2020 Q4	2/11/2021	421	0.0%	17,039	12/31/2020
2020 Q3	11/12/2020	775	0.0%	18,680	9/30/2020
2020 Q2	7/31/2020	2,658	0.0%	55,474	6/30/2020
2020 Q1	5/1/2020	3,613	0.0%	57,392	3/31/2020
2019 Q4	2/14/2020	8,911	0.0%	71,902	12/31/2019